The current valuation score of Serina Therapeutics Inc is 6.14, ranking 352 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.98, which is -569.56% below the recent high of 4.59 and -587.04% above the recent low of -6.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.